You are here

Takeda

Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra

Endpoints

Mon, 06/29/20 - 10:26 am

dry eye disease

Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work

Endpoints

Thu, 06/25/20 - 10:32 am

FDA warns Takeda over aseptic processing, inadequate investigations

RAPS.org

Tue, 06/16/20 - 07:01 pm

drug manufacturing

Takeda Grants License To Neurocrine Biosciences For Seven Pipeline Programs

NASDAQ

Tue, 06/16/20 - 10:48 am

Neurocrine Biosciences

treatment-resistant depression

Takeda-partnered Shattuck nabs mighty $118M funding round for immunotherapy, autoimmune work

Fierce Biotech

Mon, 06/15/20 - 10:33 am

drug development

Takeda continues post-Shire selloff, inching closer to $10B goal

Endpoints

Thu, 06/11/20 - 12:16 pm

Shiny new startup Egle grabs a deal with Takeda for cancer research

Fierce Biotech

Thu, 06/11/20 - 11:08 am

Egle Therapeutics

Once a gem, now just a rock, Takeda punts PhIII IBD drug as rivals muscle ahead

Endpoints

Fri, 05/29/20 - 10:45 am

Takeda posts surprise profit a year after Shire mega-merger

Pharmaforum

Wed, 05/13/20 - 10:52 am

Roche’s test of novel gut target nears

EP Vantage

Tue, 05/12/20 - 11:39 am

ulcerative colitis

Ovid's lead drug shows promising efficacy signal in Fragile X syndrome study, but optimal dosing regimen is unclear for path forward

Endpoints

Fri, 05/8/20 - 10:34 am

Ovid Therapeutics

Fragile X syndrome

clinical trials

Takeda gets FDA breakthrough therapy status for mobocertinib to treat certain type of lung cancer

Pharmaceutical Business Review

Tue, 04/28/20 - 11:45 pm

metastatic non-small cell lung cancer

Takeda licenses ProThera plasma drug for use in inflammatory conditions

Fierce Biotech

Fri, 04/24/20 - 11:07 am

ProThera Biologics

inflammatory diseases

plasma-based pharmaceuticals

Takeda to sell European OTC business to cut debts

Pharmaforum

Fri, 04/24/20 - 10:53 am

Takeda, CSL forge coronavirus alliance, forgoing their own drugs in the process

BioPharma Dive

Wed, 04/8/20 - 10:33 am

drug development

Biopharma acquisitions slow, but it's not Covid-19's fault yet

EP Vantage

Wed, 04/8/20 - 10:28 am

Gilead Sciences

ANI Pharmaceuticals

Amerigen Pharma

Takeda and Evotec Enter into Gene Therapy Research Alliance

BioSpace

Mon, 04/6/20 - 09:43 pm

Takeda signs $882m rare disease alliance with Oxford biotech Evox

Pharmaforum

Fri, 03/27/20 - 10:34 am

Evox Therapeutics

Bayer inks up with “small” Indian biotech for new approach at an old target

Endpoints

Mon, 03/23/20 - 11:31 am

2 newer multiple myeloma drugs fall short in bid for wider market

BioPharma Dive

Tue, 03/10/20 - 11:58 am

Multiple Myeloma

clinical trials

Bristol-Myers Squibb

Pages